company background image

GC Cell KOSDAQ:A144510 Stock Report

Last Price


Market Cap







27 Sep, 2022


Company Financials +
A144510 fundamental analysis
Snowflake Score
Future Growth0/6
Past Performance5/6
Financial Health5/6

A144510 Stock Overview

GC Cell Corporation develops cell therapy products.

GC Cell Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for GC Cell
Historical stock prices
Current Share Price₩47,000.00
52 Week High₩125,800.00
52 Week Low₩46,450.00
1 Month Change-20.07%
3 Month Change-14.23%
1 Year Change-49.95%
3 Year Change43.95%
5 Year Change100.00%
Change since IPO-2.29%

Recent News & Updates

Mar 19
We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

We Think Green Cross Lab Cell's (KOSDAQ:144510) Robust Earnings Are Conservative

When companies post strong earnings, the stock generally performs well, just like Green Cross Lab Cell Corporation's...

Feb 22
We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

We Think Green Cross Lab Cell (KOSDAQ:144510) Can Stay On Top Of Its Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Shareholder Returns

A144510KR BiotechsKR Market

Return vs Industry: A144510 exceeded the KR Biotechs industry which returned -51.9% over the past year.

Return vs Market: A144510 underperformed the KR Market which returned -29% over the past year.

Price Volatility

Is A144510's price volatile compared to industry and market?
A144510 volatility
A144510 Average Weekly Movement6.9%
Biotechs Industry Average Movement7.3%
Market Average Movement5.9%
10% most volatile stocks in KR Market10.7%
10% least volatile stocks in KR Market3.5%

Stable Share Price: A144510 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: A144510's weekly volatility (7%) has been stable over the past year.

About the Company

2011749Park Wu

GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021.

GC Cell Corporation Fundamentals Summary

How do GC Cell's earnings and revenue compare to its market cap?
A144510 fundamental statistics
Market Cap₩698.27b
Earnings (TTM)₩52.69b
Revenue (TTM)₩251.38b


P/E Ratio


P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A144510 income statement (TTM)
Cost of Revenue₩133.16b
Gross Profit₩118.22b
Other Expenses₩65.53b

Last Reported Earnings

Jun 30, 2022

Next Earnings Date


Earnings per share (EPS)3.51k
Gross Margin47.03%
Net Profit Margin20.96%
Debt/Equity Ratio8.4%

How did A144510 perform over the long term?

See historical performance and comparison